Royce & Associates LP Has $8.06 Million Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

Royce & Associates LP grew its holdings in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 122.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 255,552 shares of the company's stock after acquiring an additional 140,584 shares during the quarter. Royce & Associates LP owned 0.45% of Astrana Health worth $8,058,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Handelsbanken Fonder AB boosted its holdings in Astrana Health by 4.7% in the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock valued at $281,000 after purchasing an additional 400 shares during the period. Swiss National Bank increased its stake in Astrana Health by 1.1% during the 4th quarter. Swiss National Bank now owns 88,444 shares of the company's stock worth $2,789,000 after acquiring an additional 1,000 shares during the period. KBC Group NV bought a new stake in shares of Astrana Health during the 3rd quarter valued at $70,000. Quarry LP acquired a new stake in shares of Astrana Health during the 3rd quarter worth $77,000. Finally, Moran Wealth Management LLC raised its stake in Astrana Health by 21.5% in the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company's stock valued at $250,000 after purchasing an additional 1,404 shares in the last quarter. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Price Performance

Shares of NASDAQ:ASTH traded up $0.07 during trading on Friday, hitting $30.89. 679,468 shares of the company were exchanged, compared to its average volume of 254,546. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20. The company has a market capitalization of $1.74 billion, a P/E ratio of 23.76, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The business's 50 day moving average is $33.97 and its 200-day moving average is $42.56.

Remove Ads

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. Equities analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ASTH. Stifel Nicolaus reduced their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Macquarie raised shares of Astrana Health to a "hold" rating in a research note on Monday, December 16th. Robert W. Baird lowered their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Bank of America reduced their target price on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Finally, Truist Financial decreased their price target on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $56.17.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.